Bio Medica Laboratories IPO — Listing Performance
Bio Medica Laboratories IPO facts & figures
| Issue category | SME |
|---|---|
| Issue open date | 21 May 2026 |
| Listing date | 29 May 2026 |
| Overall subscription | 2.19x |
| Issue price | ₹139 |
| Listing-day close | ₹115.80 (-16.69%) |
| Recent market price | ₹158 (13.67% vs issue) |
| 52-week range | ₹106.15 – ₹177 |
| Identifiers | NSE: BMLL · ISIN: INE1BKA01015 |
How the listing went
Bio Medica Laboratories listed at a discount, closing its first day 16.69% below the issue price, on moderate subscription of 2.19x.
Bio Medica Laboratories against every other debut on record
- Rank in 2026: 102 of 112 NSE debuts, on a -16.69% first-day close.
- 10th percentile of 50 SME debuts in 2026 (median 5%).
- 9th of 9 debuts in May 2026.
- Subscribed 2.19x: 27th percentile of 165 SME issues with a figure; the 65 subscribed between 1 and 5 times closed day one a median -1.34%.
- Opened 20% below issue, then added 3.31 points to the close.
- Day-one range ₹105.65 to ₹116.75: a 7.99% swing on the issue price.
- Last close ₹158 (11 Sep 2026): 13.67% above issue, against -16.69% on day one.
- 73% up its 52-week range of ₹106.15 to ₹177.
- Priced at the top of the ₹132 to ₹139 band.
- Listed 4 calendar days after close.
- All 601 SME debuts on record: median 14.22%, 79% closed above issue.
Computed over 1109 verified NSE debuts to 11 Sep 2026 · sources